key: cord-0931997-2k8n0dsf
authors: Thomas, Kristina; Ocran, Cindy; Monterastelli, Anna; Sadun, Alfredo A.; Cockerham, Kimberly P.
title: Bridging the Gap between Ophthalmology and Emergency Medicine in Community-Based Emergency Departments (EDs): A Neuro-Ophthalmology Guide for ED Practitioners
date: 2021-12-02
journal: Clin Pract
DOI: 10.3390/clinpract11040106
sha: 57e66e3e725de2ffd932a08f29849ca7fb2c32eb
doc_id: 931997
cord_uid: 2k8n0dsf

Coordination of care for patients with neuro-ophthalmic disorders can be very challenging in the community emergency department (ED) setting. Unlike university- or tertiary hospital-based EDs, the general ophthalmologist is often not as familiar with neuro-ophthalmology and the examination of neuro-ophthalmology patients in the acute ED setting. Embracing image capturing of the fundus, using a non-mydriatic camera, may be a game-changer for communication between ED physicians, ophthalmologists, and tele-neurologists. Patient care decisions can now be made with photographic documentation that is then conveyed through HIPAA-compliant messaging with accurate and useful information with both ease and convenience. Likewise, external photos of the anterior segment and motility are also helpful. Finally, establishing clinical and imaging guidelines for common neuro-ophthalmic disorders can help facilitate complete and appropriate evaluation and treatment.

As physicians, we are most comfortable in clinical situations that focus on our own scope of practice. However, we may be faced with medical conditions that we do not routinely manage. This may result in a gap in our knowledge and/or skill set that makes us apprehensive. This problem is well highlighted in the case of patients presenting to a community-based ED with neuro-ophthalmic complaints. Such cases can often fall outside of the comfort zone for all physicians involved, including the ophthalmologist, ED physician, neurologist, and radiologist. The goal of this article is to bring awareness to this gap and provide guidelines and recommendations to increase confidence in physicians as it pertains to common neuro-ophthalmic complaints. In doing so, we hope to optimize the quality of care for the patient. We believe that image acquisition and communication via HIPAA-compliant texts are key to enhancing the quality of care.

Ophthalmology is often not a required clinical rotation in medical school, leaving physicians with minimal exposure to the specialty [1, 2] . In 2014, only 18% of medical schools required a clinical ophthalmology rotation in the United States [2] . Most ophthalmologists often have clinical practices that are limited to cataract surgery and common ophthalmic diagnoses, such as dry eyes, glaucoma, diabetes, and macular degeneration. Keeping current with neuro-ophthalmic diagnosis and management is not something the average ophthalmologist can readily accomplish. Thus, many community-based hospitals have little or no ophthalmic coverage, leaving ED physicians unable to obtain adequate consultation. In cases where there is a call group available to the ED, their scope of knowledge regarding complex orbit and neuro-ophthalmology can potentially be limited.

Another confounding issue is that tele-neurology has grown quickly and often times has to make recommendations without visualization of the posterior segment of the eye [3] . Because radiology protocols for neuro-ophthalmic issues are rarely established, the imaging that is obtained can be incorrect or inadequate for accurate diagnosis. For similar reasons, tele-radiology can also have its limitations, with general radiologists misinterpreting critical image findings.

Furthermore, in the authors' experience, advances in laboratory workup for differential neuro-ophthalmology diagnoses are typically not covered in most ED training programs. This leaves our new generation of emergency physicians with gaps in knowledge as it pertains to the standard of care for this subspeciality practice. This proves more difficult given that neuro-ophthalmic emergencies can be very severe and can cause permanent visual loss and even death. It is crucial for the emergency physician to appropriately work up and manage the neuro-ophthalmic patient during their ED stay.

The purpose of the guide is to bridge the gap between ophthalmologists and emergency physicians. Using a case-based approach, we will describe five common neuro-ophthalmic clinical vignettes that can be encountered based on the authors' clinical experiences.

A 75-year-old Caucasian woman with a history of well-controlled hypertension and hypercholesterolemia presents to the ED with complaints of a new-onset headache. She describes her headache as constant and refractory to over-the-counter pain relievers. Her physical examination is unremarkable. She has no ocular complaints, and no eye examination is performed. A non-contrast computed tomography (CT) scan of the brain is performed and reported to be normal. She is discharged with a prescription for Vicodin. Two weeks later, she returns to the ED with a worsened headache and blurred vision. The ophthalmologist on call is consulted by telephone. Visual acuity is noted to be 20/25 in both eyes (OU), pupils are round reactive to light, and no afferent pupillary defect is present. The patient has small pupils that precluded an easy view to the back of the eye with a direct ophthalmoscope. Attempts to check intraocular pressure are unsuccessful as the tonometer would not calibrate. A slit lamp examination is not done as the machine is not working. A CT and computed tomography angiogram (CTA) are performed at the recommendation of the tele-neurology doctor on call, both of which are normal. No labs are ordered. The patient is instructed to see the ophthalmologist in the morning. When the patient wakes up the next morning, her vision is worse. On examination in the ophthalmologist's office, her visual acuity has decreased to 20/400 right eye (OD) and 20/25 left eye (OS).

Giant cell arteritis (GCA) is a common disorder that presents to the ED and should be high on the differential for all elderly patients presenting with a headache, visual loss, or diplopia [4, 5] . Table 1 presents the most common presenting symptoms. Asking the right questions is crucial in preventing permanent blindness. On further questioning, the patient denied jaw claudication and temporal tenderness but did complain of ear pain and eye ache. Other historical clues that can be helpful include polymyalgia rheumatica, weight loss, fatigue, and abdominal pain due to mesenteric ischemia [6, 7] . Laboratory evaluation should include the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and complete blood count including platelet count [8, 9] . A list of the most commonly abnormal lab values for the disease process are listed in Table 2 . These laboratory tests are elevated at diagnosis in most patients and crucial to monitoring disease activity [8, 9] . However, 20% of patients have normal laboratory testing [6] . CRP is much more sensitive than ESR, but the combination of all three is the most helpful and also guides management [6, 8, 9] . Acute serum amyloid A (A-SAA) is less readily available but also highly sensitive [9] . Magnetic resonance imaging (MRI) with and without gadolinium of the orbits and temporal artery may be very helpful [5, 6, 8, 9] . A CT scan does not pick up the vasculitis but an ultrasound of the temporal arteries may [8] . GCA can cause enhancement of the optic nerve or orbit on the MRI; it also can cause enhancement of the periosteum and temporalis muscle surrounding an occluded or partially occluded temporal artery [7, 8] . If there is a history sufficiently suspicious for GCA (even if laboratory tests and imaging normal), the standard of care is to place the patient on 40 mg of prednisone (if no visual symptoms or signs) and refer for a temporal artery biopsy within two weeks [7] [8] [9] . Rheumatology is then consulted, and the patient may be switched to a steroid sparing agent like methotrexate or tocilizumab (Actemra) as the prednisone is tapered slowly [7, 10] . Monitoring always includes repeating laboratory values. If a patient has transient visual obscurations (graying or blacking out) or blurred vision due to choroidal nonperfusion or double vision, the prednisone dose should be at least 60 mg PO each morning with food [8, 9] . If the ESR and CRP are very elevated, a significant thrombocytosis is present and/or the MRI shows extensive inflammation and/or the patient has already lost vision in one eye, the patient should be treated with high doses of IV steroids (methylprednisolone 250 mg q6 h) as an inpatient [8, 9] . The characteristic severe visual damage is not reversible, but IV steroids usually prevent contralateral visual loss. Bilateral occipital lobe infarcts have been described. These patients can also have increased morbidity from stroke, myocardial infarctions, or aortic aneurysmal rupture if not treated [6, 8, 9] . ESR-erythrocyte sedimentation rate, CRP-C-Reactive protein, PLT-platelet.

A 25-year-old woman with a past medical history of polysubstance abuse presents to the ED with a chief complaint of severe headaches that wake her from sleep and are present on awakening. She has tried NSAIDS without any improvement. She admits to alcohol, marijuana, and methamphetamine use and asks for Vicodin. Her physical examination is normal, and a non-contrast CT of the brain is normal. She is discharged with a limited supply of Vicodin and referred to outpatient neurology for migraine management. Her insurer is Medicaid, and she finds it difficult to visit a neurologist who will accept her insurance. She returns to the ED seven additional times with the same complaint. On her most recent visit, she complains of transient visual obscurations that gray out or black out her vision for seconds to minutes. She is again referred to Neurology and this time to Ophthalmology as well. Again, no one accepts her insurance and she presents to the ED for an eighth visit. On this visit, she complains of severe central visual loss bilaterally and on examination is unable to see more than the "big E" on the Snellen eye chart bilaterally. Her pupils are round but minimally reactive to light. No afferent pupillary defect (APD) is present. A fundoscopic exam is not obtained given that she is uncooperative (crying hysterically), there is no protocol for pupil dilation, and a non-mydriatic camera is unavailable. The ophthalmologist on call is slow to answer and the patient is admitted but unfortunately, the call group does not cover inpatients.

Women of childbearing age who are overweight are the population most at increased risk for idiopathic intracranial hypertension (high intracranial pressure with no specific cause) [14] [15] [16] [17] . It can also occur in women of normal BMI as well as men [18] [19] [20] . Exposure to steroids, doxycycline, or other medications can trigger this disorder [16, 18, 19] .

Early morning headaches should raise concern for increased intracranial pressure and/or an intracranial mass. The headaches often get worse when laying down (gravity dependent) and can be accompanied by transient visual loss when changing from lying to sitting or standing [18, 21, 22] . Increased intracranial pressure (ICP) is serious and must be addressed. Patients who complain of early morning headaches should always have their eyes examined for papilledema whether or not they have visual symptoms [18, 21, 22] . High Intracranial pressure (ICP) causes insidious visual field loss that begins in the periphery and is seldom noticed early on [15, 18, 21, 23] . In some patients, diplopia also occurs due to the sixth cranial nerve being stretched across the petrous ridge [15, 19] .

The clinical history is critically important in this case too. Key symptoms are listed in Table 3 . Patients should be asked about transient graying out or blacking out of vision especially when going from lying down or sitting to standing [15, 19, 21] . This patient ideally would have been referred to ophthalmology at the initial visit and had a non-mydriatic photo taken of the optic nerve. Rather than a non-contrast CT scan, an MRI/MRV of the brain would have been the imaging study of choice [18, 19] . Venous sinus thrombosis can cause increased ICP [24] . While in the ED, a lumbar puncture should be performed in the lateral decubitus position to document opening pressure but also cells, glucose, and protein [19, 21, 25 ]. An elevated protein should prompt an MRI of the spine as a spinal tumor may be causing the increased ICP [19, 25] . The differential diagnosis also includes indolent infectious diseases, such as tuberculosis and inflammatory entities including sarcoidosis [25] . Table 3 . Clinical manifestations of increased ICP and optimal management in the ED setting [15, 19, 21] .

Headache often worse in the am or wakes patient from sleep This is a very treatable pathophysiology, especially if identified early. Patients are placed on acetazolamide-Diamox Sequels provide extended release-and can be dosed at 500 mg PO BID [18, 19] . When caught early, vision is preserved. Weight loss alone may recommended in mild cases with minor symptoms and preserved visual function (vision, color, visual field, and mild papilledema). Once the process has caused central visual loss, the prognosis is guarded and admission for acetazolamide, and lumboperitoneal or ventriculoperitoneal shunting is the standard of care [15, 18, 19, 26] . Venous sinus stenting is also an option in select patients. Optic nerve sheath fenestration is also an option but most helpful before the loss of central vision [19, 21, 25, 27] .

A 40-year-old woman presents to the ED with neck pain and non-specific neurologic symptoms including numbness, tingling, and headaches. She denies any other symptoms. A non-contrast CT of her brain is performed, which is normal. Tele-neurology is consulted, but her symptoms do not fit the stroke protocol, so no recommendations are made. The patient is discharged without any specific instructions for follow-up.

Four weeks later she returns to the ED with bilateral visual loss. She first notices visual blurring several days prior to presentation. She denies any other neurologic symptoms, has no family history of vision problems, and is otherwise healthy on no medications. On examination she is unable to see anything on the eye chart but can appreciate light. Her pupils are round, reactive to light, and without an afferent pupillary defect. The anterior segment, IOP, and eye movements are normal. The ophthalmologist on call is contacted and recommends transfer to the university hospital 90 miles away. Tele-neurology is contacted, and they recommend a CT/CTA, which are both normal. They also recommend transfer to a university. A transfer is requested but all universities in the state were on diversion and refused transfer. Attempts to see the fundus with a direct ophthalmoscope are unsuccessful.

Devastating unilateral or bilateral visual loss can occur due to a wide variety of causes. The differential diagnosis includes compressive, infectious, inflammatory, toxic, vascular, neoplastic, or hereditary causes [28] [29] [30] . The initial evaluation in the ED can be very helpful in guiding therapy and preserving whatever vision is present. When a patient presents with visual blurring, the first step is to determine if the problem is in the retina or the optic nerve by taking a history and performing eye signs (i.e., vitals) including red desaturation, Amsler grid testing, and fundus photography [19, 31] . The classic symptoms of retina vs optic nerve symptoms are presented in Table 4 . Once it has been determined that it is an optic nerve issue, the age of the patient will guide the work-up even more than the appearance of the nerve. Prior to the advent of MR imaging, vague neurological symptoms were difficult to evaluate. Both multiple sclerosis and neuromyelitis optica have characteristic findings on MRI and lumbar puncture [28] [29] [30] . Both are serious diseases that cause both visual and/or neurologic disabilities that can be permanent. However, treatment can be sight-saving as described in Figure 1 . Table 5 presents the most common etiologies of bilateral vs unilateral visual loss. A non-contrast CT is an inadequate test for this population. If the testing is done prior to visual loss, the patient can be treated with IV steroids and referred for outpatient initiation of definitive therapy [31] [32] [33] [34] . Distinguishing between MS-related optic neuritis and NMO-related optic neuritis is of prime importance because early initiation of effective immunosuppressive therapy is key to preventing relapses and permanent disability-see 

A 50-year-old man presents with acute onset of double vision. His eye vitals are otherwise normal. He has a past medical history significant for diabetes, hypertension, and 

Eye vitals, fundus photo CBC, ESR, CRP, RPR, Quantiferon MRI of brain and orbit with/without GAD Eye vitals including fundus photo ANA, ACE, RPR, Quantiferon Anti-aquaporin-4 antibody (AQP4) MRI of brain and orbit with/without GAD Lumbar puncture Table 6 . Signs and symptoms differentiating Multiple Sclerosis Optic Neuritis and NMO-related Optic Neuritis [25, 26, 29, 30] .

Unilateral visual loss better than 20/100 improves in 6-8 weeks Unilateral or bilateral visual loss worse than 20/100 and often permanent

Can be retrobulbar or with disc edema Eye pain worse on eye movement More common in women than men

Can be retrobulbar or with disc edema Eye pain worse on eye movement More common in women than men Short regions of enhancement on MRI orbits

Long regions of optic nerve enhancement that extend to the chiasm and may be bilateral. Longitudinally extensive transverse myelitis (LETM) that spans 3 or more vertebral segments Periventricular plaques on MRI brain Subcortical and deep white matter lesions on T2-weighted or fluid-attenuated inversion recovery sequences. Diencephalic lesions around the third ventricle, thalamus, hypothalamus, and midbrain. Dorsal brainstem adjacent to the fourth ventricle also reported that it causes intractable hiccups, nausea, and vomiting. Nystagmus, dysarthria, dysphagia, ataxia and ophthalmoplegia (multiple cranial nerves causing dysmotility) can also occur.

Can also present with antidiuretic hormone secretion, narcolepsy, hypothermia, hypotension, hypersomnia, obesity, hypothyroidism, hyperprolactinemia, amenorrhea, galactorrhea, and behavioral changes.

LP: leukocytosis LP: oligoclonal bands

A 50-year-old man presents with acute onset of double vision. His eye vitals are otherwise normal. He has a past medical history significant for diabetes, hypertension, and hypercholesterolemia. He denies headache or eye pain. The ophthalmologist on call was unable to be reached. The tele-neurologist recommended a non-contrast CT/CTA, which was reported to be normal. No additional testing was done, and the patient was discharged and told to follow-up with an ophthalmologist. One week later, the patient is found down and arrives at the ED in an ambulance. The patient never regains consciousness and passes away from a ruptured aneurysm.

Managing double vision can prove equally as challenging as managing visual loss without an accurate ophthalmic examination. In a university-based ED setting, patients are typically seen in person by the ophthalmology residents on call, who are in turn supervised by a neuro-ophthalmologist. The neuro-ophthalmologist is then able to confirm a clinical diagnosis of a cranial nerve palsy or any other etiology of double vision. Depending on the diagnosis, the appropriate radiologic imaging protocol is followed and then interpreted by a neuro-radiologist. In the community-based ED setting, this stepwise evaluation and approach is not readily available. In this setting, a very helpful starting point is to take comprehensive external photos of the patient in the nine positions of gaze (i.e., straight ahead, up, down (with eyelids held up), left, right etc.). A list of the recommended diagnostic work up for common causes of double vision are presented in Table 7 . CT scan of orbits (include corneal views) TSH, free T3 and T4, Thyroid stimulating immunoglobulin Table 7 . Cont.

Myasthenia Gravis [43] [44] [45] [46] [47] Double vision worse at end of day or with reading Any deviation pattern possible Associated with drooping of eyelid (ptosis) CT scan of chest looking for thymoma Acetylcholine binding, blocking and modulating antibodies and anti-musk Orbital Fracture [48] [49] [50] Recent trauma to orbit with limitation of up gaze (or less commonly lateral and downgaze) CT scan of orbit to look for blow out fracture Pituitary apoplexy [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] Any or all cranial nerves can be involved Non-contrast CT will typically identify the parasellar hemorrhage and necrosis. IV corticosteroids should be initiated and urgent transfer to a hospital with Neurosurgery.

Orbital Apex Syndrome [62] [63] [64] [65] [66] [67] [68] [69] Any or all cranial nerves can be involved Orbital pain and visual field/visual loss also typically present MRI of orbits/brain with and without GAD Differential includes mucor, aspergillosis, non-specific inflammatory process, sarcoidosis, and lymphoma. ENT and ophthalmology consultation. Admit for IV corticosteroids and anti-fungal medications. 

A 58-year-old Caucasian man did a video visit with his primary care physician, in which he complained of severe pain in the distribution of his herpes zoster that had occurred years before. No vesicles were visible. He was placed on nonsteroidal antiinflammatory during the day and Tylenol with codeine at bedtime. Despite receiving the Pfizer COVID vaccination seven months earlier, he presented to the ED with a fever, fatigue, muscle aches, sinus congestion, and a cough. COVID PCR testing was positive, but chest X-ray was normal. A comprehensive metabolic panel and complete blood count were normal. He was discharged to quarantine at home. Two days later, the patient returned to the ED with acute loss of vision in both eyes to 20/400, no relative afferent pupillary defect was present, and fundus photography in the ED with non-mydriatic camera was normal. Additional laboratory assessments that were found to be abnormal included elevated erythrocyte sedimentation rate (40), C-reactive protein (33) , and D dimers (2000). Chest CT revealed ground glass changes consistent with COVID-19; pulse ox revealed diminished saturation of 88%. A non-contrast head CT was normal, but an MRI of the brain and orbits revealed a large occipital stroke. The patient was admitted for Decadron, anticoagulation, and supplemental oxygen. Access to the monoclonal antibody was denied. The inflammatory markers and D dimer normalized, and pulmonary function improved. The visual loss was permanent.

COVID-19 (SARS-CoV-2) infections classically present with symptoms of fever, cough, fatigue, muscle aches, and neurologic alterations that result in loss of smell and taste [80] [81] [82] . The neurologic and ocular manifestations are less well known, and the understanding of optimal management is in evolution. It has been postulated, however, that live virus can potentially be found in the tear film [83] [84] [85] [86] . Additionally, the virus can travel via ACE2 receptors through intact ocular epithelium and the endothelial lining of organs [84, 87] . Ocular symptoms can be as mild as hemorrhagic conjunctivitis to as vision-threatening as retinal vascular occlusions and posterior ischemic optic neuropathy as listed in Table 8 [88, 89] . Though the literature is limited, there have been several reported cases of the latter. In these cases, the typical presentation to the ED is with complaints of acute, painless, monocular, or binocular vision loss in the setting of a previous or recent diagnosis of COVID-19 (though this has also been reported in patients with a previous COVID-19 diagnosis > 3 months) [90] . Oftentimes, these patients have multiple chronic conditions that make them more susceptible to a more severe disease course. Positive patients with elevated inflammatory markers (IL-6, CRP, ESR, and fibrinogen) and d-dimer are at the highest risk for visual loss [91] [92] [93] . Thus, it is very important for the clinician to have a high index of suspicion for the patient that presents with elevated markers. Given that COVID-19 lowers the threshold for thrombotic complication, especially in the chronically ill, Decadron and anti-coagulation may prevent visual loss in patients with cytokine storm and hypercoagulability [89, 94] . In certain cases, this may mean expedited complete visual recovery whereas in other instances, vision may improve spontaneously over time if at all [16] . 

Patients who present with acute visual loss, double vision, or other neuro-ophthalmic disorders often create a diagnostic and management challenge for the community hospital ED. Neuro-ophthalmology is outside of the comfort zone for most ED physicians, teleneurologists, ophthalmologists, and radiologists. Gathering key historical information, performing eye vitals, and capturing fundus and/or gaze images helps to guide the workup in the ED and the interface with tele-neurology and the on-call ophthalmologist. Failing to obtain the appropriate laboratory evaluations, imaging, and diagnostic interventions in the ED can result in permanent visual loss or death. Especially in communities where managed care complicates timely work-up on our neediest patients, the ED plays a central role in care for these patients. We hope that these clinical guidelines for neuro-ophthalmic patients can be integrated into EHR systems to help facilitate high-quality patient care in community EDs across the country. 

The authors declare no conflict of interest.

A Proposal to Improve Ophthalmic Education in Medical Schools

The State of Ophthalmology Medical Student Education in the United States and Canada

Acute Vision Loss

Gradual loss of vision in adults

Giant cell arteritis: Ophthalmic manifestations of a systemic disease. Graefe's Arch

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis

Update on giant cell arteritis

Diagnosis and management of giant cell arteritis: Major review

Tocilizumab, an effective treatment for relapsing giant cell arteritis

Prevalence of a Normal C-Reactive Protein with an Elevated Erythrocyte Sedimentation Rate in Biopsy-Proven Giant Cell Arteritis

A Predictive Model for Temporal Artery Biopsy in the Setting of Suspected Giant Cell Arteritis: A Validation Study

American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension

Idiopathic intracranial hypertension: Diagnosis, monitoring and treatment

Bariatric surgery for the treatment of idiopathic intracranial hypertension

Incidence of Idiopathic Intracranial Hypertension Parallels Rising Rate of Obesity

The diagnosis and management of idiopathic intracranial hypertension and the associated headache. Ther

Idiopathic Intracranial Hypertension (Pseduotumor Cerebri): Epidemiology and Pathogenesis. Available online: www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis

Idiopathic intracranial hypertension in men

Idiopathic intracranial hypertension: Ongoing clinical challenges and future prospects

The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

The Importance of Visual Field Testing in Idiopathic Intracranial Hypertension

Cerebral venous sinus stenting for pseudotumor cerebri: A review

Available online: www.uptodate.com/contents/lumbar-puncture-technique-indications-contraindications-and-complications-in-adults

Ophthalmology for the Primary Care Physician

Optic Nerve Sheath Fenestration-Indications and Techniques

Diffusion-Weighted Imaging and Post-contrast Enhancement in Differentiating Optic Neuritis and Non-arteritic Anterior Optic Neuropathy

Optic neuritis

Patient attitudes towards NMOSD diagnosis and treatment: Final survey results

Long term efficacy outcomes with inebilizumab treatment in NMOSD: The N-MOmentum trial

Inebilizumab treatment reduces the occurrence of pain in NMOSD patients

Evaluation of infusion reactions and infusion times in the N-MOmentum study of inebilizumab for NMOSD

Pharmacodynamic modeling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorder

Binocular diplopia. A practical approach

Acute-onset diplopia

Diagnostic Approach to Diplopia

Trochlear nerve palsy

Isolated Abducens Nerve Palsy: Update on Evaluation and Diagnosis

A New Era in the Treatment of Thyroid Eye Disease

Imaging Investigation of Thyroid Eye Disease

Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations

A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature. Front

International Consensus Guidance for Management of Myasthenia Gravis

Ocular myasthenia gravis: A review

Considerations for the Management of Medial Orbital Wall Blowout Fracture

Orbital blowout fractures: A novel CT measurement that can predict the likelihood of surgical management

Analysis of the effect of repair materials for orbital blowout fracture on complications

Presentation, management and outcomes in acute pituitary apoplexy: A large single-centre experience from the United Kingdom

Management Of Endocrine Disease: Pituitary tumour apoplexy

Management of pituitary apoplexy

New oral anticoagulants and pituitary apoplexy

Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy

UK guidelines for the management of pituitary apoplexy

Conservative management of pituitary tumor apoplexy

Clinical Features of Pituitary Apoplexy

Management and outcomes of pituitary apoplexy

Orbital Apex Syndrome: A Review

Orbital apex disorders: Imaging findings and management

Orbital apex syndrome from bacterial sinusitis without orbital cellulitis

Traumatic superior orbital fissure syndrome: Review of literature and report of three cases

Orbital apex syndrome: A clinico-anatomical diagnosis

Successful delayed treatment of the traumatic orbital apex syndrome by nasal endoscopic decompression surgery

Orbital apex disorders: A case series

Orbital Apex Syndrome Resulting from Mixed Bacterial Sphenoid Sinusitis

The clinical features and outcomes of Tolosa-Hunt syndrome

Periarteritic Lesions of the Carotid Siphon with the Clinical Features of a Carotid Infraclinoidal Aneurysm

Painful ophthalmoplegia: Its relation to indolent inflammation of the cavernous sinus

ICHD-II Diagnostic Criteria for Tolosa-Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus

Nosological Entities?: The Tolosa-Hunt syndrome

A rare case of septic cavernous sinus thrombosis as a complication of sphenoid sinusitis

Cavernous sinus thrombosis due to ipsilateral sphenoid sinusitis

Orbital Subperiosteal Abscess Associated with Mandibular Wisdom Tooth Infection: A Case Report

Bilateral posterior fracture-dislocation of shoulder following seizures secondary to cavernous sinus venous thrombosis-A rare association

Atypical Cavernous Sinus Thrombosis: A Diagnosis Challenge and Dilemma

Traumatic Persistent Trigeminal Artery -Cavernous Sinus Fistula Treated by Transcatheter Arterial Embolization

Treatment of direct carotid cavernous sinus fistulae. Various therapeutic approaches and results in 148 cases

Paradoxical worsening with superior ophthalmic vein thrombosis after gamma knife radiosurgery for dural arteriovenous fistula of cavernous sinus: A case report suggesting the mechanism of the phenomenon

Characteristics and Therapeutics. Cells 2021

Characteristics of SARS-CoV-2 and COVID-19

Coronavirus Disease 2019-COVID-19

Ask the Expert: How COVID-19 Affects the Eyes

SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology

Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban

Acute Vision Loss in a Patient with COVID-19

Severe Bilateral Vision Loss in 2 Patients With Coronavirus Disease

Do Normal D-dimer Levels Reliably Exclude Cerebral Sinus Thrombosis? Stroke

Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response

Management of Acute Retinal Ischemia